Adjournment of Annual Meeting to 1 October 2026

MyCelx Technologies Corporation

17 September 2026

 

17 September 2026

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM: MYX or MYXR)

Adjournment of Annual Meeting to 1 October 2026

MYCELX announces that the Annual Meeting convened for 17 September 2026 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London EC1A 7BL was opened. However, a quorum was not present in accordance with the Company’s Bylaws, which require the presence (in person or by proxy) of shareholders holding in excess of 50 per cent. of the Company’s total issued share capital.

The Company has received 11,320,446 votes, representing approximately 46.5 per cent. of its total issued share capital, all of which were voted in favour of the resolutions to be proposed at the Annual Meeting.

In the absence of a quorum, and in accordance with the Company’s Bylaws, the meeting was adjourned shortly after commencement.

The adjourned Annual Meeting will be held at 1650 International Court, Suite 100, Norcross, Georgia 30093, U.S.A. at 9.00 a.m. (EST) / 2.00p.m. (London time) on 1 October 2026.

For further information please contact:

MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker) Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance) Harriet Ward (Corporate Broking) Jasper Berry / Michael Johnson (Sales)	Tel: [phone] Tel: [phone]

 

END